Skip to main content
. 2019 Oct 21;41(2):202–231. doi: 10.1210/endrev/bnz010

Figure 1.

Figure 1.

Proposed anti-inflammatory mechanisms in the kidney mediated by SGLT2 inhibition in diabetes. SGLT2, sodium glucose co-transporter 2.